RecruitingNCT03400345

Human Upper Extremity Allotransplantation: F/U Protocol

Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol


Sponsor

Johns Hopkins University

Enrollment

60 participants

Start Date

Jul 25, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria5

  • Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
  • Completes the protocol informed consent form.
  • Consents to sample collection and storage (biopsies).
  • USA citizen or equivalent.
  • Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.

Exclusion Criteria2

  • Candidate has not received an upper extremity allotransplant.
  • Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03400345


Related Trials